Bruce E. Spotts

710 total citations
8 papers, 481 citations indexed

About

Bruce E. Spotts is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bruce E. Spotts has authored 8 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 2 papers in Urology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bruce E. Spotts's work include Urinary and Genital Oncology Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Esophageal Cancer Research and Treatment (2 papers). Bruce E. Spotts is often cited by papers focused on Urinary and Genital Oncology Studies (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Esophageal Cancer Research and Treatment (2 papers). Bruce E. Spotts collaborates with scholars based in United States. Bruce E. Spotts's co-authors include David G. Bostwick, Roxann M. Neumann, Liang Cheng, Amy L. Weaver, Ajay Nehra, Kathleen S. Egan, John C. Cheville, Bradley C. Leibovich, Scott E. Strome and Kerry D. Olsen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Bruce E. Spotts

8 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce E. Spotts United States 5 337 123 118 87 83 8 481
Alba Greco United States 8 120 0.4× 73 0.6× 16 0.1× 36 0.4× 132 1.6× 12 357
Luis G. Gómez United States 9 117 0.3× 168 1.4× 8 0.1× 25 0.3× 90 1.1× 14 412
Paul Barrett United Kingdom 8 104 0.3× 157 1.3× 4 0.0× 43 0.5× 50 0.6× 14 298
Jin Tanahashi Japan 10 143 0.4× 61 0.5× 6 0.1× 41 0.5× 35 0.4× 17 272
Spasenija Savic-Prince Switzerland 5 359 1.1× 161 1.3× 81 0.7× 49 0.6× 57 0.7× 6 438
Osama Shahin Switzerland 6 511 1.5× 61 0.5× 203 1.7× 87 1.0× 69 0.8× 8 556
MARCIA SHAW United Kingdom 9 33 0.1× 105 0.9× 6 0.1× 153 1.8× 27 0.3× 14 364
Mark A. Chastain United States 8 38 0.1× 107 0.9× 4 0.0× 122 1.4× 35 0.4× 9 279
Juan A. Reyna United States 4 253 0.8× 65 0.5× 55 0.5× 43 0.5× 42 0.5× 8 333
A P van der Meijden Netherlands 6 573 1.7× 82 0.7× 242 2.1× 52 0.6× 119 1.4× 10 643

Countries citing papers authored by Bruce E. Spotts

Since Specialization
Citations

This map shows the geographic impact of Bruce E. Spotts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce E. Spotts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce E. Spotts more than expected).

Fields of papers citing papers by Bruce E. Spotts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce E. Spotts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce E. Spotts. The network helps show where Bruce E. Spotts may publish in the future.

Co-authorship network of co-authors of Bruce E. Spotts

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce E. Spotts. A scholar is included among the top collaborators of Bruce E. Spotts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce E. Spotts. Bruce E. Spotts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Brissett, Anthony E., Kerry D. Olsen, Jan L. Kasperbauer, et al.. (2002). Merkel cell carcinoma of the head and neck: A retrospective case series. Head & Neck. 24(11). 982–988. 80 indexed citations
2.
Driscoll, David J., Francisco J. Puga, Joseph A. Dearani, et al.. (2000). Operation for partial atrioventricular septal defect: a forty-year review. Journal of Thoracic and Cardiovascular Surgery. 119(5). 880–890. 69 indexed citations
3.
Cheng, Liang, Roxann M. Neumann, Ajay Nehra, et al.. (2000). Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer. 88(7). 1663–1670. 114 indexed citations
4.
Cheng, Liang, John C. Cheville, Roxann M. Neumann, et al.. (1999). Survival of patients with carcinoma in situ of the urinary bladder. Cancer. 85(11). 2469–2474. 3 indexed citations
5.
Neumann, Roxann M., Liang Cheng, John C. Cheville, et al.. (1999). LONG-TERM FOLLOW-UP OF PATIENTS WITH CARCINOMA IN SITU OF THE URINARY BLADDER. The Journal of Urology. 116–116. 1 indexed citations
6.
Cheng, Liang, Roxann M. Neumann, Amy L. Weaver, Bruce E. Spotts, & David G. Bostwick. (1999). Predicting Cancer Progression in Patients With Stage T1 Bladder Carcinoma. Journal of Clinical Oncology. 17(10). 3182–3187. 103 indexed citations
7.
Cheng, Liang, John C. Cheville, Roxann M. Neumann, et al.. (1999). Survival of patients with carcinoma in situ of the urinary bladder. Cancer. 85(11). 2469–2474. 107 indexed citations
8.
Dechet, Christopher, et al.. (1999). LONG-TERM OUTCOME AFTER PARTIAL NEPHRECTOMY FOR RENAL CELL CARCINOMA WITH NORMAL CONTRALATERAL KIDNEY. The Journal of Urology. 165–165. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026